$13.83
1.64% yesterday
NYSE, Sep 24, 10:18 pm CET
ISIN
US58470H1014
Symbol
MED

Medifast Inc Stock price

$13.83
-0.26 1.85% 1M
-0.32 2.26% 6M
-3.79 21.51% YTD
-5.32 27.78% 1Y
-95.82 87.39% 3Y
-150.58 91.59% 5Y
-13.70 49.76% 10Y
+9.93 254.62% 20Y
NYSE, Closing price Wed, Sep 24 2025
-0.23 1.64%
ISIN
US58470H1014
Symbol
MED

Key metrics

Basic
Market capitalization
$152.0m
Enterprise Value
$-10.7m
Net debt
positive
Cash
$162.7m
Shares outstanding
11.0m
Valuation (TTM | estimate)
P/E
41.9 | negative
P/S
0.3 | 0.4
EV/Sales
negative | negative
EV/FCF
4.4
P/B
0.7
Dividends
DPS
$0.00
Yield 1Y | 5Y
0.0% | 3.4%
Growth 1Y | 5Y
-100.0% | -100.0%
Payout 1Y | 3Y
0.0% | 52.3%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$480.5m | $383.0m
EBITDA
$15.9m | $-1.4m
EBIT
$2.2m | $-16.9m
Net Income
$3.6m | $-10.3m
Free Cash Flow
$-2.4m
Growth (TTM | estimate)
Revenue
-37.6% | -36.4%
EBITDA
-75.1% | -104.4%
EBIT
-95.6% | -186.6%
Net Income
-87.6% | -593.8%
Free Cash Flow
-104.4%
Margin (TTM | estimate)
Gross
73.8%
EBITDA
3.3% | -0.4%
EBIT
0.5%
Net
0.8% | -2.7%
Free Cash Flow
-0.5%
Financial Health
Equity Ratio
73.9%
Return on Equity
1.0%
ROCE
1.0%
ROIC
2.0%
Debt/Equity
0.0
More
EPS
$0.3
FCF per Share
$-0.2
Short interest
19.3%
Employees
504
Rev per Employee
$1.2m
Show more

Is Medifast Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

Medifast Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Medifast Inc forecast:

4x Hold
44%
5x Sell
56%

Analyst Opinions

9 Analysts have issued a Medifast Inc forecast:

Hold
44%
Sell
56%

Financial data from Medifast Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
480 480
38% 38%
100%
- Direct Costs 126 126
37% 37%
26%
355 355
38% 38%
74%
- Selling and Administrative Expenses 348 348
32% 32%
72%
- Research and Development Expense 4.50 4.50
2% 2%
1%
16 16
75% 75%
3%
- Depreciation and Amortization 14 14
4% 4%
3%
EBIT (Operating Income) EBIT 2.23 2.23
96% 96%
0%
Net Profit 3.64 3.64
88% 88%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Medifast Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medifast Inc Stock News

Neutral
Business Wire
10 days ago
BALTIMORE--(BUSINESS WIRE)--With more than 90% of U.S. adults classified as metabolically unhealthy1, the silent crisis of metabolic dysfunction continues to escalate. This condition can be linked to a range of challenges, including being overweight and having difficulty maintaining energy, vitality and long-term health and wellbeing. To address this issue, Medifast, the 40+ year old health and...
Neutral
Seeking Alpha
about 2 months ago
Medifast, Inc. (NYSE:MED ) Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ET Company Participants Daniel R. Chard - Executive Chairman & CEO James P.
Neutral
The Motley Fool
about 2 months ago
Medifast (MED) Q2 Revenue Falls 37%
More Medifast Inc News

Company Profile

Medifast, Inc. is a health and wellness company, which engages in the manufacture and distribution of healthy living products and programs. Its platform includes OPTAVIA, which offers its costumers lifelong transformation, one healthy habit at a time. The company was founded by William Vitale in 1980 and is headquartered in Baltimore, MD

Head office United States
CEO Daniel Chard
Employees 504
Founded 1981
Website medifastinc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today